BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11601747)

  • 1. Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD).
    Karnak D; Beng-sun S; Beder S; Kayacan O
    Respir Med; 2001 Oct; 95(10):811-6. PubMed ID: 11601747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD.
    Brandén E; Koyi H; Gnarpe J; Gnarpe H; Tornling G
    Respir Med; 2005 Jan; 99(1):20-6. PubMed ID: 15672844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
    Hahn DL
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):271-88, 291; quiz 291-2. PubMed ID: 10541419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae.
    von Hertzen L; Leinonen M; Surcel HM; Karjalainen J; Saikku P
    Clin Diagn Lab Immunol; 1995 Jul; 2(4):454-7. PubMed ID: 7583923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease].
    Duan Z; Liu S; Wang B
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):208-11. PubMed ID: 11802964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD.
    Miyashita N; Niki Y; Nakajima M; Kawane H; Matsushima T
    Chest; 1998 Oct; 114(4):969-71. PubMed ID: 9792563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA.
    Verkooyen RP; Van Lent NA; Mousavi Joulandan SA; Snijder RJ; van den Bosch JM; Van Helden HP; Verbrugh HA
    J Med Microbiol; 1997 Nov; 46(11):959-64. PubMed ID: 9368538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Chlamydophila pneumoniae and Mycoplasma pneumoniae IgM and IgG antibodies in Tunisian patients presenting with exacerbation of chronic obstructive pulmonary disease.
    Messous S; Trabelsi I; Grissa MH; Nouira S; Pozzetto B; Mastouri M
    Med Mal Infect; 2017 Mar; 47(2):158-163. PubMed ID: 28062246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma].
    Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A
    Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection.
    Mogulkoc N; Karakurt S; Isalska B; Bayindir U; Celikel T; Korten V; Colpan N
    Am J Respir Crit Care Med; 1999 Jul; 160(1):349-53. PubMed ID: 10390424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae infection in acute exacerbations of COPD.
    Blasi F; Legnani D; Lombardo VM; Negretto GG; Magliano E; Pozzoli R; Chiodo F; Fasoli A; Allegra L
    Eur Respir J; 1993 Jan; 6(1):19-22. PubMed ID: 8425589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic Chlamydia pneumonia infection in patients with chronic obstructive pulmonary disease].
    Mazur E; Niedźwiadek J; Chmielewska-Badora J; Gryglicka B; Kozioł-Montewka M; Milanowski J
    Pneumonol Alergol Pol; 2000; 68(5-6):261-4. PubMed ID: 11004865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease.
    von Hertzen L; Isoaho R; Leinonen M; Koskinen R; Laippala P; Töyrylä M; Kivelä SL; Saikku P
    Int J Epidemiol; 1996 Jun; 25(3):658-64. PubMed ID: 8671570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between chronic obstructive pulmonary disease and Chlamydiae pneumoniae infection].
    Zhao YN; Zhao MW; Pei F; Li XY; Yao WZ
    Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):333-7. PubMed ID: 15182501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and optimization of a commercial enzyme linked immunosorbent assay for detection of Chlamydophila pneumoniae IgA antibodies.
    Frikha-Gargouri O; Gdoura R; Znazen A; Ben Arab N; Gargouri J; Ben Jemaa M; Hammami A
    BMC Infect Dis; 2008 Jul; 8():98. PubMed ID: 18655722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of chlamydia-pneumoniae-specific immunoglobulin M antibody and acute exacerbations of asthma in childhood].
    Sato S; Kawashima H; Kashiwagi Y; Ushio N; Nagai M; Takekuma K; Hoshika A
    Arerugi; 2007 Nov; 56(11):1378-83. PubMed ID: 18059151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serological tests detecting Chlamydophila pneumoniae-specific immunoglobulin M antibody.
    Miyashita N; Obase Y; Fukuda M; Shoji H; Mouri K; Yagi S; Yoshida K; Ouchi K; Oka M
    Intern Med; 2006; 45(20):1127-31. PubMed ID: 17106155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations.
    Lieberman D; Ben-Yaakov M; Lazarovich Z; Ohana B; Boldur I
    Eur J Clin Microbiol Infect Dis; 2001 Oct; 20(10):698-704. PubMed ID: 11757970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between serological markers for Chlamydophila pneumoniae and the development of abdominal aortic aneurysm.
    Karlsson L; Björck M; Pärsson H; Wanhainen A
    Ann Vasc Surg; 2011 Apr; 25(3):322-6. PubMed ID: 21126854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease.
    Droemann D; Rupp J; Goldmann T; Uhlig U; Branscheid D; Vollmer E; Kujath P; Zabel P; Dalhoff K
    Am J Respir Crit Care Med; 2007 Apr; 175(8):791-7. PubMed ID: 17290045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.